Watfa Al-Mamari is a developmental pediatrician who established the first developmental pediatric clinics in Oman in 2011. She has worked closely with academic institutions to ensure that developmental pediatrics is included in the curriculum for both undergraduate and postgraduate students. She has a special interest in autism and led the team to establish a national program in Oman to screen children for autism at 18 months of age.
Al-Mamari graduated from Sultan Qaboos University in Muscat, Oman, and later did her residency and fellowship at McGill University in Montreal, Canada.
Watfa Al-Mamari
Developmental pediatrician
Sultan Qaboos University
From this contributor
How one doctor made Oman a leader on autism in the Middle East
Developmental pediatrician Watfa Al-Mamari is building an autism program in Oman from the ground up.
How one doctor made Oman a leader on autism in the Middle East
Explore more from The Transmitter
Not playing around: Why neuroscience needs toy models
Amid the rise of billion-parameter models, I argue that toy models, with just a few neurons, remain essential—and may be all neuroscience needs.
Not playing around: Why neuroscience needs toy models
Amid the rise of billion-parameter models, I argue that toy models, with just a few neurons, remain essential—and may be all neuroscience needs.
Psychedelics research in rodents has a behavior problem
Simple behavioral assays—originally validated as drug-screening tools—fall short in studies that aim to unpack the psychedelic mechanism of action, so some behavioral neuroscientists are developing more nuanced tasks.
Psychedelics research in rodents has a behavior problem
Simple behavioral assays—originally validated as drug-screening tools—fall short in studies that aim to unpack the psychedelic mechanism of action, so some behavioral neuroscientists are developing more nuanced tasks.
New organoid atlas unveils four neurodevelopmental signatures
The comprehensive resource details data on microcephaly, polymicrogyria, epilepsy and intellectual disability from 352 people.
New organoid atlas unveils four neurodevelopmental signatures
The comprehensive resource details data on microcephaly, polymicrogyria, epilepsy and intellectual disability from 352 people.